Neogen Chemicals Accepts Rs 152 Crore Additional Insurance Claim for Dahej Facility

CHEMICALS
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Neogen Chemicals Accepts Rs 152 Crore Additional Insurance Claim for Dahej Facility

Neogen Chemicals has accepted an additional Rs 152 crore insurance claim following the disruption at its Dahej SEZ site. The company’s total claim receivable now stands at Rs 316.49 crore, significantly offsetting recognized losses of Rs 362.90 crore on a consolidated basis. With a net financial impact of Rs 14.08 crore, the firm is currently conducting trial runs at its new replacement plant while shifting key production to alternative manufacturing sites.

Neogen Chemicals Secures Rs 152 Crore Insurance Boost

Additional insurance claim of Rs 152 crore accepted; total claim receivables reach Rs 316.49 crore.
Consolidated recognized loss of Rs 362.90 crore results in a net financial impact of Rs 14.08 crore.

Reader Takeaway: Improved claim recovery offsets major property loss; production shift to alternate plants stabilizes earnings outlook.

What just happened

Neogen Chemicals has formally accepted an additional insurance settlement of Rs 152 crore regarding the incident at its Dahej SEZ facility. Including previous payouts and salvage proceeds, the company has now secured or accounted for total insurance receivables of Rs 316.49 crore. The settlement addresses claims related to property, plant, and equipment damage, as well as business interruption costs.

Why this matters

The company’s financials for FY 2024-25 reflect a consolidated loss of Rs 362.90 crore. With the insurance claim receivable now booked at Rs 348.82 crore, the net impact on the company’s bottom line is contained at Rs 14.08 crore. This substantial recovery limits the long-term balance sheet damage caused by the facility suspension.

What changes now

Operations at the MPP3 facility and associated infrastructure at Dahej remain suspended. However, the company is progressing with the construction of a replacement plant, which has already entered the trial run phase for completed sections. To maintain output for critical customers, management has successfully migrated select specialty product production to other manufacturing facilities.

Risks to watch

Future settlements are still contingent on final assessments regarding asset reinstatement values and ongoing business interruption costs. While current mitigation strategies have stabilized output, full recovery depends on the timely operational restart of the entire Dahej site.

What to track next

Watch for the final commissioning timeline of the replacement plant and the eventual full restoration of the Dahej SEZ operations, which will be the primary catalyst for normalizing margins.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.